BioSpace News Archive

Nkarta, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to NKX101 for treatment of acute myeloid leukemia (AML).

The Series B investment will enable the Oxford-based company to expand its award-winning artificial intelligence (AI) portfolio into new indications and extend into new high-growth markets.

ILC Dover, Inc. (“ILC Dover”, “ILC” or the “Company”), today announced the acquisition of KSE Scientific (“KSE”), a sterile solutions manufacturer which specializes in the production of Water for Injection (WFI) and related media and buffer solutions for biopharma, cell & gene therapy, tissue banking and medical device end-markets.

Palleon Pharmaceuticals today announced the appointment of Denis Patrick, Ph.D., to its Board of Directors.

iECURE today announced that it has entered into an exclusive agreement with the University of Pennsylvania (Penn) to develop next-generation lipid nanoparticles (LNP) for liver gene editing applications.

Synergy HealthCare Alliance (Synergy HCA) is pleased to welcome Real Time Medical Systems (Real Time) as its newest strategic partner.

Affinivax, Inc. today announced the appointment of Vanya Sagar, M.P.A., as its Chief People Officer.

Motus GI Holdings, Inc. announced that the U.S. Patent and Trademark Office has issued patent no. 11,185,625, which is titled, “Colon cleaning system with automatic self-purging features.”.

Ampio Pharmaceuticals today released the following letter to stockholders from its Chief Executive Officer, Mike Martino.

In furtherance of its program, the Company filed US Provisional Patent Application No. 63/283,051, titled “Detection of Therapeutic Psychedelic State,” as of November 23, 2021.